NCT02121899终止不适用
LUNG CAncerREgistry: An Open Registry to Measure the Impact of Adding RNA Expression Testing (myPlan Lung Cancer) on Treatment Decisions and to Assess Disease-free Survival With Long-term Follow-up in Newly Diagnosed Early Stage Lung Adenocarcinoma Patients (LUNG CARE Registry)
适应症
试验速览
- 阶段
- 不适用
- 状态
- 终止
- 入组人数
- 44
- 主要终点
- Percentage change from Pre-Test treatment recommendation to Post-test treatment initiated
研究概览
简要总结
This registry is intended to measure the effect of myPlan Lung Cancer™ test has on influencing treatment decisions of Oncologists when added to standard clinical-pathological parameters in patients with early stage NSCLC.
The sponsor is conducting two parallel registries, with one directed at Surgeons (ONC003) and the other at Oncologists (ONC006). This registry is specific to Oncologists (ONC006).
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Diagnosis of early stage non-small cell lung adenocarcinoma
- •Sub-population staging (IA, IB or IIA) as judged by the standard of practice at the investigational site
- •Resection of tumor within previous 2 months of enrollment
- •ECOG performance of 0-2
- •A minimum life expectancy of six months
- •Exclusion Criteria
- •Previous myPlan Lung Cancer test performed
- •Pre-operative radiation or chemotherapy for NSCLC
- •Post-operative radiation or chemotherapy for NSCLC
- •Enrollment in a separate clinical trial restricting treatment options
- •Unable to provide informed consent
排除标准
- 未提供
结局指标
主要结局
Percentage change from Pre-Test treatment recommendation to Post-test treatment initiated
时间窗: 3 months
The percentage change from the recorded Pre-Test treatment recommendation by the oncologist versus the Post-Test treatment initiated.
次要结局
- Assessment of disease free survival from resection to relapse or death(3 years)
研究者
相似试验
终止
不适用
Registry Measuring the Impact of Adding RNA Expression Testing on Referral Decisions in Early Stage Lung Cancer Patients and Assessing the Disease-free Survival With Long-term Follow-upLung AdenocarcinomaLung CancerNSCLCNCT02121925Myriad Genetic Laboratories, Inc.227
撤回
不适用
Maximizing Benefit of Lung Cancer Screening Incidental Findings of Cardiovascular, Respiratory and Breast MeasuresCoronary DiseaseEmphysema or COPDBreast DensityNCT05900544University of Montana300
终止
不适用
Lung Cancer Case Registry and Tissue ResourceLung CancerNCT00250848University of New Mexico750
终止
不适用
Observational Study of Best Supportive Care With or Without Surgery, Chemo or Radiotherapy in Pts With Carcinoma of LungLung CancerNCT00822016New Mexico Cancer Care Alliance25
招募中
不适用
Rural Illinois Lung Cancer Screening InitiativeLung CancerNCT06084078Southern Illinois University10,000